Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Althea Group Holdings Ltd. ( (AU:AGH) ) has issued an update.
Althea Group Holdings Limited is addressing challenges from a current voluntary suspension from the ASX due to past compliance issues, with efforts to strengthen governance and resolve the suspension. Despite these hurdles, the company is making strategic advancements, particularly in North America, through a partnership with Boston Beer Company’s cannabis subsidiary and a joint venture with Flora Growth Corp., positioning itself in the growing cannabis-infused beverage market. These efforts are expected to drive future shareholder value, while operational changes are underway in its pharmaceutical business to adapt to market dynamics.
More about Althea Group Holdings Ltd.
Althea Group Holdings Ltd is a global leader in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. The company operates through two distinct business units: Peak Processing Solutions, focused on recreational cannabis products for adult consumers, and Althea, which offers a range of cannabis-based medicines available by prescription. Althea operates in highly regulated cannabis markets globally, with key operations in North America, Europe, and Australia.
YTD Price Performance: 13.33%
Average Trading Volume: 603,453
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$13.78M
For a thorough assessment of AGH stock, go to TipRanks’ Stock Analysis page.
